You make a valid point. But MSB is currently walking a fine line with regards to how they spend their money. Do they spend money on marketing, to prop up the share price in the short term? or use the funding on trials and corporate operations to benefit the organisation in the longer term?. I will take the later?
You make a valid point. But MSB is currently walking a fine line...
Add to My Watchlist
What is My Watchlist?
